{"entity":{"type":"insider","cik":"0001709900","url":"/insider/0001709900","json_url":"/insider/0001709900.json","name":"Mattessich Antony C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2017-12-13","last":"2024-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Mattessich Antony C.","source":"filing","n_filings":9,"first_seen":"2017-12-13","last_seen":"2024-02-06"}],"transactions":[{"id":2434057,"accession":"0001104659-24-011195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-011195","line_url":"/filing/0001104659-24-011195#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19642.0,"shares_display":"19,642","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":95460.12,"total_display":"95,460.12","total_whole":"95,460","shares_owned_after":588701.0,"shares_owned_after_display":"588,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":2212696,"accession":"0001104659-24-010231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-010231","line_url":"/filing/0001104659-24-010231#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18338.0,"shares_display":"18,338","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":90773.1,"total_display":"90,773.10","total_whole":"90,773","shares_owned_after":427943.0,"shares_owned_after_display":"427,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8758955,"accession":"0001104659-23-098019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-098019","line_url":"/filing/0001104659-23-098019#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":24765.0,"total_display":"24,765.00","total_whole":"24,765","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-30","filed_date":"2023-09-05","scope":"insider"},{"id":8014310,"accession":"0001104659-23-014678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-014678","line_url":"/filing/0001104659-23-014678#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19669.0,"shares_display":"19,669","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":83396.56,"total_display":"83,396.56","total_whole":"83,397","shares_owned_after":446281.0,"shares_owned_after_display":"446,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":4282437,"accession":"0001104659-21-108777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-108777","line_url":"/filing/0001104659-21-108777#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.89,"price_display":"9.89","price_state":"stated","total_value":49450.0,"total_display":"49,450.00","total_whole":"49,450","shares_owned_after":102900.0,"shares_owned_after_display":"102,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-24","scope":"insider"},{"id":8417140,"accession":"0001104659-19-034632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034632","line_url":"/filing/0001104659-19-034632#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":112400.0,"total_display":"112,400.00","total_whole":"112,400","shares_owned_after":97900.0,"shares_owned_after_display":"97,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-10","scope":"insider"},{"id":6014450,"accession":"0001104659-18-053039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-053039","line_url":"/filing/0001104659-18-053039#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":119000.0,"total_display":"119,000.00","total_whole":"119,000","shares_owned_after":57900.0,"shares_owned_after_display":"57,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-21","scope":"insider"},{"id":6041429,"accession":"0001104659-18-051518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-051518","line_url":"/filing/0001104659-18-051518#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16900.0,"shares_display":"16,900","price_per_share":6.23,"price_display":"6.23","price_state":"stated","total_value":105287.0,"total_display":"105,287.00","total_whole":"105,287","shares_owned_after":37900.0,"shares_owned_after_display":"37,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-13","scope":"insider"},{"id":4846348,"accession":"0001104659-17-073177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-073177","line_url":"/filing/0001104659-17-073177#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001709900","owner_name":"Mattessich Antony C.","owner_display_name":"Mattessich Antony C.","owner_url":"/insider/0001709900","role":"Director, Officer (President and C.E.O)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and C.E.O.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":4.29,"price_display":"4.29","price_state":"stated","total_value":90090.0,"total_display":"90,090.00","total_whole":"90,090","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Director, Officer (President and CEO)","n_filings":9,"first_seen":"2017-12-13","last_seen":"2024-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709900","retrieved_at":"2026-08-23T23:43:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}